Grown Rogue International (GRUSF) Assets Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Assets Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.35% |
| Sep 30, 2025 | 184,514,363.33% |
| Jun 30, 2025 | 170,835,205.82% |
| Mar 31, 2025 | 25.69% |
| Apr 30, 2021 | 128.58% |
| Jan 31, 2021 | 80.07% |
| Oct 31, 2020 | 28.37% |
| Jan 31, 2020 | -51.38% |
| Oct 31, 2019 | -45.35% |
| Oct 31, 2018 | 84.12% |
| Aug 31, 2018 | -22.70% |
| May 31, 2018 | -87.78% |
| Feb 28, 2018 | -76.43% |
| Nov 30, 2017 | -71.61% |
| Aug 31, 2017 | -91.22% |
| May 31, 2017 | -98.81% |
| Feb 28, 2017 | -98.67% |
| Nov 30, 2016 | 254.15% |
| Aug 31, 2016 | 409.89% |
| May 31, 2016 | 702.48% |